CuraSen Therapeutics lands $54.5 mln Series A
CuraSen Therapeutics Inc, a developer of therapies to treat neurodegenerative diseases, has raised $54.5 million Series A financing. New Leaf Venture Partners led the round.
17 October 2018•1 min read
CuraSen Therapeutics Inc, a developer of therapies to treat neurodegenerative diseases, has raised $54.5 million Series A financing. New Leaf Venture Partners led the round.
